This document provides a summary of Melissa Meehan's professional experience and qualifications. She currently works as a Transition Nurse Specialist at UC San Diego Health System, coordinating care for high-risk patients to improve care transitions and eliminate gaps in care. Previously she held several roles coordinating care for patients with conditions such as liver disease, cancer, and infectious diseases. She has over 25 years of experience in clinical research, care coordination, and nursing.

1. Melissa Meehan, RN
XXXXXXXXXXX
San Diego, CA
760-846-4098
misrn@mac.com
Professional Experience:
07/13 – present Transition Nurse Specialist, CNS, CN V, Care Coordination Department, University of
California San Diego Heath System, San Diego, CA
The Transition Nurse Specialist's (TNS) is a blended advance practice nurse role aimed at
improving transitions of care for high risk patients and eliminate gaps in the continuum of
care. Responsible for coordinating a comprehensive program of social work and case
management services in the department of care coordination for high risk patients. TNS
integrates concepts derived from case management, communication, care coordination
theory, and nurse educator spheres of influence to ensure a network of providers and
community resource to assist patients and/or family to optimize their level of self-efficacy.
Utilize proven quality improvement frameworks to identify and redesign care transition
models to improve patient and family outcomes and organizational goals such as reduce
readmission rates. Collaborate and cultivates collegial relationships with intrer-professional
team on designated units and/or within specific disease populations. TNS provides
clinically informative variables to identify high risk patients who have a modifiable risk by
conducting:
• In depth Interview for modifiable risk & intervention planning:
o Inter professional collaboration for patient centered discharge plan
o Patient/family/caregiver education – ‘Teach Back’
o Schedule follow-up appointments prior to discharge with primary care provider and
specialists within 7 day post discharge
o Identify appropriate additional interventions
o Review discharge instructions with patient – time out for accuracy & teach back
o Connect with PCP/community clinic
o Warm hand off/post discharge availability to providers
• Follow-up calls post discharge within 48 -72 hours & as needed
• Provide feedback to PCP, Specialists, and other care providers
• Accessible to patient, Home Health, Skilled Nursing Facility, and other inter
professional team members
• Data collection & Analysis
Participate in the development and implementation of guidelines, evidence based practice,
pathways and other process and performance improvement activities. Assist in the
development/writing of protocols; designing assessment tools; preparing abstracts,
presentations, and reports. TNS also participate in interdepartmental and inter-facility
committees, community agencies, and professional associations. Additionally, currently
managing automated post-discharge call system for UCSD Health, monitoring responses
and addressing identified issues.
11/09 – 01/13 Post-Liver Transplant and Hepatology Coordinator, Division of Organ Transplant,
Scripps Green Hospital, La Jolla, CA
Responsible for the planning, coordination, and case management of all aspects of patient
care for the throughout the continuum of service—from initial referral to follow-up care for
hepatology and immediate post-operative through long term post-liver transplant outpatient
follow-up. Secondarily responsible for the same roles in nephrology and post-kidney and/or
pancreas patient populations. Serve as the primary case management coordinator for the
interdisciplinary team, including: physicians, nurses, social workers, dieticians,
pharmacists, financial analysts, case managers and support staff. Develop, coordinate,
implement and evaluate educational programs and projects for patients, personnel and the
community. Collect and document data to meet clinical, financial and regulatory
requirements. Participated in the development of guidelines, protocols, pathways and
other performance improvement activities. Participate in research activities. Serve as a
patient advocate throughout the patient care process. An additional component of this
position includes providing direct patient care as the clinic nurse for the unit procedure
room, including activities such as medication administration (PO, IM, SQ, and IV), prepping
and assisting with minor procedures and biopsies, and post-procedure direct patient
evaluation and monitoring until discharge from procedure room.

2. Professional Experience (continued):
03/09 – 12/09 Home Health Registered Nurse, Interim Healthcare of San Diego County, Escondido, CA
Responsible for intermittent home visits to assist identified patients in maintaining the
highest level of independence and physical and emotional well being within their home.
Facilitate direct patient care and clinical interventions as deemed necessary (such as,
ostomy or wound care, nutritional supplementation, IV administration, and specimen
collection). Provide education to promote self or caregiver management of long-term
chronic or new medical diagnosis; including, hypertension, diabetes, congestive heart
failure, and chronic obstructive pulmonary disease. Maximize patient’s rehab-ability and
make referrals for necessary durable medical equipment and appropriate evaluation by
supportive services. Collect and document data to meet clinical, financial and regulatory
requirements. Serve as a patient advocate throughout the process and communication
liaison with physicians overseeing and ordering patient’s direct home care.
09/04 – 02/09 Clincal HBS Program and Live-Transplant Coordinator, Hepatobiliary Surgery and Live
Liver Donation, Center for Liver Disease and Transplantation (CLDT), Cedars-Sinai
Medical Center, Los Angeles, CA
Responsible for the planning, coordination, and case manager of all aspects of care for the
patients throughout the continuum of service—from initial referral to follow-up care for a
large pancreatic hepatobiliary and surgical oncology practice, as well as live liver donor
program patients. Served as the primary coordinator for the interdisciplinary team,
including: physicians, nurses, social workers, dieticians, pharmacists, financial analysts,
case managers and support staff. Developed, coordinated, implemented and evaluated
educational programs and projects for patients, personnel and the community. Collected
and documented data to meet clinical, financial and regulatory requirements. Participated
in the development of guidelines, protocols, pathways and other performance improvement
activities. Participated in research activities. Served as a patient advocate throughout the
patient care process. Component of position also included taking 24-hour Liver Transplant
Call for organ procurement, transplant surgeries, and first line patient issues for all patients
under the care of the CLDT (including Liver Transplant, Hepatology, and Hepatobiliary
Surgery).
10/01 – 02/09 Clinical Program Coordinator, Neuroendocrine Tumor Center, Cedars-Sinai Medical
Center, Los Angeles, CA
Coordinated the development of a new program focused on providing comprehensive,
cutting edge, multi-disciplinary care for individuals suffering from neuroendocrine tumors.
Responsible for the planning and coordination of all aspects of care for the patients
throughout the continuum of service—from initial referral to life long follow-up care. Served
as the primary coordinator and case manager for the interdisciplinary team, including:
endocrinologist, oncologist, surgeons, pathologist, radiologist, nurses, and support staff.
Developed, coordinated, implemented and evaluated educational programs and projects
for patients, personnel and the community. Collected and documented data to meet
clinical, financial and regulatory requirements. Participated in research activities.
Component of position also required 24-hour call responsibility for this patient population
and first line patient contact for all issues and concerns.
10/01 – 08/04 Research Nurse II, Center for Liver Disease and Transplantation, Cedars-Sinai Medical
Center, Los Angeles, CA
Managed all aspects of multiple drug company, NIH, and investigator sponsored phase I-IV
clinical trials. Collaborated closely with Program Director and Study Chair on study-related
issues; Assisted in the development/writing of protocols, designing CRFs, reviewing and
evaluating safety data, abstracts, presentations, and final study reports. Ensured all study-
related activities required of sponsor are being performed and documented properly.
Coordinated clinical and research activities, recruited and provided primary care and
education to patients and study participants from various liver disease and pre/post liver
transplant patient populations.
06/00 – 10/01 Clinical and Research Nurse Coordinator, Pediatric Infectious Disease, Cedars-Sinai
Medical Center, Los Angeles, CA
Managed all aspects of multiple drug company and investigator sponsored phase I-IV
clinical trials. Collaborated closely with Program Director, and Study Chair on study-

3. Professional Experience (continued):
related issues; Ensured all study-related activities required of sponsor are being performed
and documented properly. Coordinated clinical and research activities, recruited and
provided primary care and education to patients and study participants from various
pediatric infectious disease populations (including HIV/AIDS).
02/00 – 05/00 Clinical Research Associate, Contract, Kennedy Consultants, LLC, Oakland, CA
Responsibilities included writing Standard Operating Procedures (SOPs) for several
clients, as well as other varied contracted services.
02/00 – 02/00 Good Clinical Practice (GCP) Training Course, Co-Instructor, United States (US)
Army/Royal Thai Army, Bangkok, Thailand
Prepared and presented with my partner at Kennedy Consulting, LLC, a three day course
on US FDA GCP as training for Thai and US Doctors and Nurses running studies in
Thailand with protocols under US INDs. Followed up at individual sites to insure good
comprehension of course information and reviewed any topics that seemed unclear at the
sites.
07/99 – 01/00 Clinical Research Nurse, John Wayne Cancer Institute, (JWCI),
Santa Monica, CA
Coordinated research activities, recruited and provided primary care and education to
study participants on multiple phase I-II and one international, multi-center, phase II/III
JWCI sponsored cancer vaccine melanoma trials.
01/97 – 03/99 Clinical Research Associate, Regional Monitor, Kern McNeill International, Chatham
Township, NJ
Responsible for data evaluation, protocol training and monitoring for six adult multi-center
phase II-III Hepatitis B and two international multi-center phase II pediatric HIV clinical drug
trials. I maintained thirteen sites in several geographic regions; performed drug
accountability audits, monitored to ensure all study-related activities required of sponsor
are being performed and documented properly, in-service education, and data query
resolution activities on all trials.
09/95 – 02/96 Clinical and Research Nurse Coordinator, Comprehensive Liver Disease and Treatment
Center, Los Angeles, CA
Managed all aspects of multiple drug company and investigator sponsored phase I-IV
clinical trials. Collaborated closely with Program Director and Study Chair on study-related
issues; Assisted in the development/writing of protocols, designing CRFs, reviewing and
evaluating safety data, abstracts, presentations, and final study reports. Ensured all study-
related activities required of sponsor are being performed and documented properly.
Coordinated clinical and research activities, recruited and provided primary care and
education to patients and study participants from various liver disease and pre/post liver
transplant patient populations.
12/91 – 09/95 Clinical and Research Nurse Coordinator, Liver Transplantation Services, Cedars-Sinai
Medical Center, Los Angeles, CA
Managed all aspects of multiple drug company and investigator sponsored phase I-IV
clinical trials. Collaborated closely with Program Director and Study Chair on study-related
issues; Assisted in the development/writing of protocols, designing CRFs, reviewing and
evaluating safety data, abstracts, presentations, and final study reports. Ensured all study-
related activities required of sponsor are being performed and documented properly.
Coordinated clinical and research activities, recruited and provided primary care and
education to patients and study participants from various liver disease and pre/post liver
transplant patient populations.
07/88 – 10/91 Staff Nurse I-II, Cedars-Sinai Medical Center, Los Angeles, CA
General Surgery/Liver Transplant Unit
07/87 – 07/88 Nurse Internship for New Graduates, Cedars-Sinai Medical Center, Los Angeles, CA:
Worked as a staff Registered Nurse, (RN), rotating through seven surgical and one
medical unit over the course of a year.

4. Education: MSN, CNS, Point Loma Nazarene University
(RN to MSN/CNS Bridge Program) San Diego, CA – May 2013 (thesis defended and
published May 2015)
AAN, Cerritos College, Norwalk, CA – May 1987
- Numerous training courses and conferences related to transitions of care, case
management, clinical nurse specialist, liver disease and liver transplantation,
pancreatico-hepatobiliary surgery, neuroendocrine disease and tumors (1989-present)
- Basic Training in Clinical Monitoring, Pharmaceutical Education and Research
Institute, San Francisco, CA –1997
- Various training courses/seminars related to Good Clinical Practice and FDA
regulations (1997-2008)
License: California Board of Registered Nurses (CBRN) since 1987
License Number: 415908 active through 1/31/2017
(CNS licensure submitted and pending at CBRN as of August 2015)
Certification: Clinical Nurse Specialist (CNS)
Certificate: 4444 active through 1/31/2017
ABTC Certification for Clinical Transplant Coordinators (since 03/09/07)
Honors & Memberships: Invited Member of Sigma Theta Tau International Honor Society of Nursing
American Case Management Association member since 2014
National Association of Clinical Nurse Specialist since 2015
Abstracts:
M. Meehan, E. Haley, E. Fink, A. Degan-De Cort, G. Phillips. Care Transitions: Innovative Role for Clinical Nurse
Specialist (CNS) as an Advance Practice Expert Leading Inter Professional Team Approach to Improve Transitions
of Care and Quality Outcomes in High Risk Readmission Vulnerable Populations, National Association of Clinical
Nurse Specialists 2015 Annual Conference, Coronado, CA, March 2015
E. Haley, E. Fink, M. Meehan, K. Field, T. Gilbert, A. Hassidim, S. Roundtree, RN, K. Winslow. Innovative
Approach to Reducing Readmission by Targeting High Risk Patients with Modifiable Risk, American Case
Management Association National Conference, Chicago, IL, April 2014
Cavazzoni E, Meehan MD, Shackleton C, Sher L, Vierling JM, Nissen N, Martin P, Poordad F, Tran T, Ayoub W,
Colquhoun SD. A Pre-Liver Transplant Scoring System to Predict Post-Transplant Vascular Invasion in Patients
with Hepatocellur Carcinoma (HCC), Pacific Coast Surgical Association, 75th
Annual Meeting, Maui, Hawaii,
February 2004
Cavazzoni E, Meehan MD, Shackleton C, Sher L, Vierling JM, Nissen N, Martin P, Poordad F, Tran T, Ayoub W,
Colquhoun SD. Pre-transplant Adjuvant Therapy for Hepatocellular Carcinoma Results in a Survival Disadvantage
Hepatology 2003; 38, 4: S1: 758A.
Cavazzoni E, Meehan MD, Shackleton C, Sher L, Vierling JM, Nissen N, Martin P, Poordad F, Tran T, Ayoub W,
Colquhoun SD. Predicting Post-transplant Survival with Hepatocellular Carcinoma: An Assessment of Current
Staging Systems and Individual Parameters Hepatology 2003; 38, 4: S1: 770A.
Ayoub W, Cavazzoni E, Meehan MD, Colquhoun S, Vierling J, Shackleton C, Martin P, Tran T, Poordad F, Nissen
N. Adjuvant Chemotherapy Does Not Affect Survival of Incidental Hepatocellular After Liver Transplantation
Hepatology 2003; 38, 4: S1: 755A.
Shackleton C, Colquhoun S, Nissen N, Cavazzoni E, Meehan M, Vierling J, Martin P, Poordad P, Tran T: The Myth
of “Hung-up” Bilirubin in Live Donor Liver Transplantation. North Pacific Surgical Association, Portland OR,
November 14-15, 2003.
Sher LS, Meehan M, Rojter S, Podesta L, Hoffman A, Lopez R, Villamil F, Vierling J, Pan S-H, Geller S, Petrovic 4
Arnaout W, Morgan G, Makowka L: Prograf for Rescue of Chronic Rejection (CR) Following Orthotopic Liver
Transplantation (OLTX). International Congress Meeting on New Immunosuppressive Drugs, Minneapolis, MN.
August 27-30,1995.

5. Abstracts (continued):
Sher LS, Meehan M, Podesta L, Pan S-H, Hoffman A, Lopez R, Geller S, Petrovic L,
Villamil F, Vierling J, Morgan G, Arnaout W, Talke A, Makowka L: Rescue Use of Prograf Following Orthotopic
Liver Transplantation (OLTX). International Joint Congress on Liver Transplantation, London UK, September 27-
30, 1995.
Armaut W, Sher LS, Hoffman A, Waxman A, Lopez R, Podesta L, Lugo D, Chen S, Morgan G, Williams C, Meehan
M, Makowka L: Radiosotope Scanning of AFP Producing Tumors Utilizing an Anti-AFP Antibody: a Pilot Study.
Hepatology 22(4):186A, 1995.
Sher LS, Eiras-Hreha G, Kornhauser D, King, Shang-Ying P, Podesta L, Hoffman A, Meehan M, Joshi A, Noguchi
H, Pan S-H, Cramer D, and Makowka L: Safety and Pharmacokinetics (PK) of Brequinar Sodium (BQR) in Liver
Allograft Recipients on Cyclosporine (CYA) and Steroids. International Liver Transplant Society, Ontario, Canada,
October 6-8, 1993. Hepatology 18(3)4:746, September, 1993.
Publication:
Cavazzoni E, Meehan MD, Shackleton C, Sher L, Vierling JM, Nissen N, Martin P, Poordad F, Tran T, Ayoub W,
Colquhoun SD. A Pre-Liver Transplant Scoring System to Predict Post-Transplant Vascular Invasion in Patients
with Hepatocellur Carcinoma (HCC) Archives of Surgery. Publication pending
Presentations:
“Care Transitions: Innovative Role for Clinical Nurse Specialist (CNS) as an Advance Practice Expert Leading Inter
Professional Team Approach to Improve Transitions of Care and Quality Outcomes in High Risk Readmission
Vulnerable Populations” M. Meehan; E. Haley; E. Fink; A. Degan-De Cort; G. Phillips; poster presentation,
National Association of Clinical Nurse Specialists 2015 Annual Conference, Coronado, CA, March 2015.
“Innovative Approach to Reducing Readmission by Targeting High Risk Patients with Modifiable Risk” E. Haley; E.
Fink; M. Meehan; K. Field; T. Gilbert; A. Hassidim; S. Roundtree, RN; K. Winslow; poster presentation,
American Case Management Association National Conference, Chicago, IL, April 2014.
“Predicting Post-transplant Survival with Hepatocellular Carcinoma: An Assessment of Current Staging Systems
and Individual Parameters” poster presentation, American Association for the Study of Liver Disease, Boston, MA,
October 2003.
“Pre-transplant Adjuvant Therapy for Hepatocellular Carcinoma Results in a Survival Disadvantage” poster
presentation, American Association for the Study of Liver Disease, Boston, MA, October 2003.
“A Pre-Liver Transplant Scoring System to Predict Post-Transplant Vascular Invasion in Patients with Hepatocellur
Carcinoma (HCC)” oral presentation, Pacific Coast Surgical Association, 75th
Annual Meeting, Maui, Hawaii,
February 2004
“Good Clinical Practice (GCP) Training Course”, Co-Instructor, United States (US) Army/Royal Thai Army,
Bangkok, Thailand, February 9-13, 2000
"Rescue Use of Prograf Following Orthotopic Liver Transplantation (OLTX)". poster presentation, Joint Congress
on Liver Transplantation in London, UK, September 28, 1995.
"Prograf for Rescue of Chronic Rejection Following Orthotopic Liver Transplantation (OLTX)". oral presentation,
International Congress on New Immunosuppressive Drugs in Minneapolis, Minnesota, August, 1995.
"Current Protocols in Immunosuppression - Highlighting Brequinar, FK506, Cyclosporine G". oral presentation,
Southern California Transplant Coordinators Meeting, Loma Linda University Medical Center, March 16, 1994,
"Safety and Pharmacokinetics (PK) of Brequinar Sodium (BQR) in Liver Allograft Recipients on Cyclosporine (CYA)
and Steroids." oral presentation, International Liver Transplantation Society Second Congress, Toronto, Canada,
October 8, 1993.
Liver Transplant Case Study. oral presentation, Transplantation Conference, Cedars-Sinai Medical Center, Los
Angeles, California, June, 1990.

6. Additional Publication Activities:
Serving as editor and collaborator for an Italian surgeon (Cavazzoni E) regarding ongoing matters of scientific
publications. (2003-present)
Makowka L, Sher S: Transplantation 2000: Past, Present and Future. In: Intra-abdominal Organ Transplantation:
2000, (L Makowka, L Sher Eds.), R.G. Landes Co.
Preparation of figures.
Podesta L, Rosenthal P, Sher L, Makowka L: Pediatric Liver Transplant. In: Seminars in Pediatric Surgery, (L
Makowka, P Rosenthal Eds.), S,L Gans & S.L. Grosfeld, 1993: 3(l):265-278. Preparation of figures.

7. Additional Publication Activities:
Serving as editor and collaborator for an Italian surgeon (Cavazzoni E) regarding ongoing matters of scientific
publications. (2003-present)
Makowka L, Sher S: Transplantation 2000: Past, Present and Future. In: Intra-abdominal Organ Transplantation:
2000, (L Makowka, L Sher Eds.), R.G. Landes Co.
Preparation of figures.
Podesta L, Rosenthal P, Sher L, Makowka L: Pediatric Liver Transplant. In: Seminars in Pediatric Surgery, (L
Makowka, P Rosenthal Eds.), S,L Gans & S.L. Grosfeld, 1993: 3(l):265-278. Preparation of figures.